TITLE: DR.

NAME: OLUWADAMILOLA MIRIAM KOLAWOLE

POSITION: SENIOR LECTURER                          SPECIALISATION: DRUG DELIVERY/IN SITU GELLING SYSTEMS/FILM                                                                                            FORMULATIONS/NANOMEDICINES

EDUCATION/TRAINING

Personal Statement

“I am a middle career scientific researcher and new drug product development enthusiast, with a passion for advancing sustainable solutions in the effective treatment of communicable and non-communicable diseases, including cancer, infection and inflammation through drug delivery technologies, using innovative, biodegradable and biocompatible materials. My work focuses on developing smart, biodegradable nanomedicines, in situ gelling and film formulations using FDA-approved pharmaceutical ingredients. In addition, my research combines Polymer Chemistry with Pharmaceutics, Biomedical Engineering, Pharmaceutical Microbiology, and Molecular Biology to develop innovative and patient-centric medicines. With a strong commitment to improving the therapeutic outcomes of cancer patients and those with microbial infections and inflammatory conditions, I constantly strive to ensure that new drug products that could be translated from the research laboratory to the clinics are developed. Also, I share my research findings during scientific conferences and publish my research outcomes in quality chemistry and pharmaceutical journals. In addition, I support the future generation of pharmacists and drug formulation scientists to acquire research and analytical skills that will help them generate breakthrough medicines. My ultimate goal is to translate research into scalable drug products and training models that address Africa’s health challenges through collaborative and interdisciplinary approaches.”

Positions, Scientific Appointments, and Honours

• Pharmaceutics and Pharmaceutical Technology Departmental Examination Officer, 2024/2025.
• Abstract Chair, Faculty of Pharmacy Scientific Conference, 2024.
• Member, MCPD, Nigeria, Module X-XII Training Committee, 2019, 2021, 2023.
• Reviewer, Journal of Macromolecular Science, Part A: Pure and Applied Chemistry, 2020; Reviewer, Molecular Pharmaceutics, 2023; Reviewer, International Journal of Nanomedicine, 2023; Reviewer, International Journal of Pharmaceutics X, 2025
• Member, Organization for Women in Science for the Developing World (OWSD), 2016-date
• Member, Royal Society of Chemistry, 2016 –date
• Editorial Member, The Nigerian Journal of Pharmaceutical Research, 2025
• Drug Carriers in Medicine and Biology Gordon Research Conference Grant, $1320, 2024.
• Royal Society of Chemistry, Grant Number R23-4644122030, £5,000, 2023
• Royal Society of Chemistry, Grant Number R21-9528830286, £4,000, 2022
• 2021- Building Research and Innovation in Nigeria’s Science NIH Grant number D43TW010134 (N4, 918,400)
• Royal Society of Chemistry Career Development Department Travel Grant, UK (£600), 2018
• Graduate School/Department of Pharmacy, University of Reading Travel Grant to attend European Chemistry Congress, Liverpool, United Kingdom (£400), 2018
• Gilchrist Educational Grant (£ 750) and The Leche Trust Award to support PhD studies (£1,000), 2018
• Department of Pharmacy, University of Reading Research fees waiver (£7, 500), 2017.
• Astra Zeneca Award for Best Performing Student in Master of Science in Drug Delivery program (2009/2010), University College London School of Pharmacy, London, United Kingdom plus cash prize of £500, 2010.

Selected Most Recent Publications /Contributions to Knowledge

• Kolawole O. M., Okeke P. K. Formulation and evaluation of fluconazole containing boronated 4 arm polyethylene glycol, polyvinyl pyrrolidone, methyl cellulose-based films for the potential treatment of Vaginal Candidiasis. Journal of Drug Delivery Science and Technology 2025; 107: 106838.
• Kolawole O. M., Khutoryanskiy V. V. Potential bladder cancer therapeutic delivery systems: a recent update. Expert Opinion on Drug Delivery 2024 volume 21 issue 9, 1311-1329
• Kolawole O. M., Abu Ellela M. Recent Advances in modified chitosan-based drug delivery systems for transmucosal applications. Int J Biol Macromolecules 2024 volume 227, part 4 page 134531
• Ogedengbe O. T., Kolawole O. M. Formulation and evaluation of fluconazole emulgels for potential treatment of vaginal candidiasis. Heliyon 2024; 10: e28206
• Kolawole O. M., Ifeanafor A. R. Ifade W., Akinleye M., Silva B. O., Akinniyi A. Formulation and evaluation of paclitaxel loaded boronated chitosan alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery. Journal of Drug Delivery Science and Technology 2023; 184: 36-49.

Collaborators/ Networks (International inclusive)

• Prof. Prasopchai Patrojanasophon, Silpakorn University, Thailand
• Michael Cook, University College London School of Pharmacy, London, United Kingdom
• Vitaliy Khutoryanskiy, University of Reading, Reading, United Kingdom
• Mahmoud Abu Ellela, Cairo University, Egypt.